|
|
|
|
|
| |
|
| |
|
|
|
Special price offers!
|
|
| |
|
|
|
Editor's Choice Reports
|
|
| |
|
|
|
Allergy & Respiratory
|
|
| |
|
|
|
Anesthesia
|
|
| |
|
|
|
Antibiotics
|
|
| |
|
|
|
Antithrombotics
|
|
| |
|
|
|
Arthritis
|
|
| |
|
|
|
Autoimmune
|
|
| |
|
|
|
Cardiology
|
-
Commercial Insight: Antidyslipidemics - Branded statins beware, generics are amongst you
-
Commercial Insight: Antidyslipidemics - The competitive cost-conscious antidyslipidemics market presents challenges
-
Commercial Insight: Antihypertensives - New challenges for a maturing market
-
Commercial Insight: Antithrombotics - Pipeline products to dampen the impact of patent expiries and cost containment initiatives
-
Commercial Insight: Cardiovascular market overview - Raft of patent expires threaten blockbusters
-
Congestive Heart Failure: Major World Markets, Volume I: Pharmaceutical Management
-
Congestive Heart Failure: Major World Markets, Volume II: Devices (Pacemaker, ICD, LVAD and Artificial Heart Markets)
-
Heart Health Food and Drinks: NPD in cardiovascular health, hypertension and cholesterol reduction
-
Innovations in Cardiovascular Disease Management: Latest surgical procedures, drugs and medical devices
-
Pipeline Insight: Heart failure Weak pipeline dominated by new indications and add-on diuretics
-
Pipeline/Commercial Insight: Antihypertensives New class opportunity offset by key patent expiries
-
Stakeholder Insight: Acute Coronary Syndromes Fresh look at ACS in Europe, what is the real picture?
-
Stakeholder Insight: Atherosclerosis - HDL, ApoA-I, Carotid MRI and 64-slice CT offer opportunities for future treatment
-
Stakeholder Insight: Atrial Fibrillation - Limited efficacy and poor safety lead to bleak outlook
-
Stakeholder Opinions: Heart Failure - When drugs do not work
-
The Asian Cardiovascular Market Outlook to 2010
-
The Cardiovascular Disorders Market Outlook to 2012
-
The Cardiovascular Market Outlook to 2011
-
The Eastern European Cardiovascular Market Outlook to 2010
-
The Latin American Cardiovascular Market Outlook to 2010
-
World Cardiovascular Drug Market (Antihypertensives, Antihyperlipidemics, Vasodilators, Anticoagulants, Diuretics and other Agents)
|
| |
|
|
|
Clinical Trials
|
|
| |
|
|
|
Company Profiles
|
| |
Public
Feeds 
